A. Razek, A. A. Poptani, and H. , MR spectroscopy of head and neck cancer, European Journal of Radiology, vol.82, pp.982-989, 2013.

J. H. Ardenkjaer-larsen, B. Fridlund, A. Gram, G. Hansson, L. Hansson et al., Increase in signal-to-noise ratio of O10,000 times in liquid-state NMR, PNAS, vol.100, pp.10158-10163, 2003.

B. E. Baysal, J. E. Willett-brozick, E. C. Lawrence, C. M. Drovdlic, S. A. Savul et al., Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas, Journal of Medical Genetics, vol.39, pp.178-183, 2002.

R. De-beer, A. Van-den-boogaart, D. Van-ormondt, W. W. Pijnappel, J. A. Hollander et al., Application of time-domain fitting in the quantification of in vivo 1 H spectroscopic imaging data sets, NMR in Biomedicine, vol.5, pp.171-178, 1992.

P. Bhattacharya, E. Y. Chekmenev, W. H. Perman, K. C. Harris, A. P. Lin et al., Towards hyperpolarized (13)C-succinate imaging of brain cancer, Journal of Magnetic Resonance, vol.186, pp.150-155, 2007.

E. M. Blanchet, S. Gabriel, V. Martucci, N. Fakhry, C. C. Chen et al., 18 F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas, European Journal of Clinical Investigation, vol.44, pp.325-332, 2014.

H. Bruhn, J. Frahm, M. L. Gyngell, K. D. Merboldt, W. Hanicke et al., Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors, Radiology, vol.172, pp.541-548, 1989.

A. Cascon, I. Comino-mendez, M. Curras-freixes, A. A. De-cubas, L. Contreras et al., Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene, Journal of the National Cancer Institute, vol.107, issue.053, 2015.

L. J. Castro-vega, A. Buffet, A. A. De-cubas, A. Cascon, M. Menara et al., Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas, Human Molecular Genetics, vol.23, pp.2440-2446, 2014.

J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater et al., Adrenal masses: characterization with in vivo proton MR spectroscopy -initial experience, Radiology, vol.245, pp.788-797, 2007.

J. Favier, J. J. Briere, N. Burnichon, J. Riviere, L. Vescovo et al., The Warburg effect is genetically determined in inherited pheochromocytomas, PLoS ONE, vol.4, p.7094, 2009.

S. Fellah, D. Caudal, D. Paula, A. M. Dory-lautrec, P. Figarella-branger et al.,

, Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?, AJNR. American Journal of Neuroradiology, vol.34, pp.1326-1333

J. Gaal, N. Burnichon, E. Korpershoek, I. Roncelin, J. Bertherat et al., Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas, Journal of Clinical Endocrinology and Metabolism, vol.95, pp.1274-1278, 2010.

V. Govindaraju, K. Young, and A. A. Maudsley, Proton NMR chemical shifts and coupling constants for brain metabolites, NMR in Biomedicine, vol.13, pp.129-153, 2000.

R. A. De-graaf, In Vivo NMR Spectroscopy: Principles and Techniques. Second Edition, 2008.

F. Haller, E. A. Moskalev, F. R. Faucz, S. Barthelmess, S. Wiemann et al., Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad, Endocrine-Related Cancer, vol.21, pp.567-577, 2014.

J. A. Hobert, J. L. Mester, J. Moline, and C. Eng, Elevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individuals, Genetics in Medicine, vol.14, pp.616-619, 2012.

A. Imperiale, F. M. Moussallieh, F. Sebag, L. Brunaud, A. Barlier et al., A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas, PLoS ONE, vol.8, p.80539, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01699803

A. Imperiale, K. Elbayed, F. M. Moussallieh, N. Reix, M. Piotto et al., Bachellier P & Namer IJ 2013b Metabolomic profile of the adrenal gland: from physiology to pathological conditions, Endocrine-Related Cancer, vol.20, pp.705-716

A. Imperiale, F. M. Moussallieh, P. Roche, S. Battini, A. E. Cicek et al., Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications, Neoplasia, vol.17, pp.55-65, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01682749

A. Imperiale, S. Battini, G. Averous, D. Mutter, B. Goichot et al., Namer IJ 2015b In vivo detection of catecholamines by magnetic resonance spectroscopy: a potential specific biomarker for pheochromocytoma diagnosis, Surgery

J. F. Jansen, H. Schoder, N. Y. Lee, H. E. Stambuk, Y. Wang et al., Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1 H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [ 18 F]FDG-PET, International Journal of Radiation Oncology, vol.82, pp.299-307, 2012.

R. Katz-brull, N. M. Rofsky, and R. E. Lenkinski, Breathhold abdominal and thoracic proton MR spectroscopy at 3T. Magnetic Resonance in Medicine, vol.50, pp.461-467, 2003.

S. Kim, N. Salibi, A. D. Hardie, J. Xu, R. P. Lim et al., Characterization of adrenal pheochromocytoma using respiratorytriggered proton MR spectroscopy: initial experience, AJR. American Journal of Roentgenology, vol.192, pp.450-454, 2009.

A. D. King, D. K. Yeung, A. T. Ahuja, G. M. Tse, H. Y. Yuen et al., Salivary gland tumors at in vivo proton MR spectroscopy, Radiology, vol.237, pp.563-569, 2005.

A. D. King, D. K. Yeung, K. H. Yu, F. K. Mo, C. W. Hu et al., Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1 H MR spectroscopy, European Radiology, vol.20, pp.165-172, 2010.

W. E. Klunk, C. Xu, K. Panchalingam, R. J. Mcclure, and J. W. Pettegrew, Quantitative 1 H and 31 P MRS of PCA extracts of postmortem Alzheimer's disease brain, Neurobiology of Aging, vol.17, pp.349-357, 1996.

J. Kurhanewicz, D. B. Vigneron, K. Brindle, E. Y. Chekmenev, A. Comment et al., Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research, Neoplasia, vol.13, pp.81-97, 2011.

L. Fur, Y. , N. F. Guye, M. Confort-gouny, S. Cozzone et al., , 2010.

, Grid-free interactive and automated data processing for MR chemical shift imaging data, Magma, vol.23, pp.23-30

N. Lendvai, R. Pawlosky, P. Bullova, G. Eisenhofer, A. Patocs et al., Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings, Endocrinology, vol.155, pp.27-32, 2014.

V. L. Martucci and K. Pacak, Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment, Current Problems in Cancer, vol.38, pp.7-41, 2014.

M. Mishkovsky, A. Comment, and R. Gruetter, In vivo detection of brain Krebs cycle intermediate by hyperpolarized magnetic resonance, Journal of Cerebral Blood Flow and Metabolism, vol.32, pp.2108-2113, 2012.

F. H. Van-nederveen, J. Gaal, J. Favier, E. Korpershoek, R. A. Oldenburg et al., An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis, Lancet Oncology, vol.10, pp.764-771, 2009.

H. P. Neumann, Z. Erlic, C. C. Boedeker, L. A. Rybicki, M. Robledo et al., Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out, Cancer Research, vol.69, pp.3650-3656, 2009.

V. Piccini, E. Rapizzi, A. Bacca, D. Trapani, G. Pulli et al., Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients, Endocrine-Related Cancer, vol.19, pp.149-155, 2012.

J. U. Rao, U. F. Engelke, F. C. Sweep, K. Pacak, B. Kusters et al., , 2015.

, Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics, Journal of Clinical Endocrinology and Metabolism, vol.100, pp.214-222

H. Ratiney, M. Sdika, Y. Coenradie, S. Cavassila, and D. Van-ormondt-d-&-graveron-demilly, Time-domain semi-parametric estimation based on a metabolite basis set, NMR in Biomedicine, vol.18, pp.1-13, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00443422

Z. J. Reitman, J. G. Karoly, E. D. Spasojevic, I. Yang, J. Kinzler et al., Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome, PNAS, vol.108, pp.3270-3275, 2011.

S. Richter, M. Peitzsch, E. Rapizzi, J. W. Lenders, N. Qin et al., Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/ paragangliomas due to succinate dehydrogenase deficiency, Journal of Clinical Endocrinology and Metabolism, vol.99, pp.3903-3911, 2014.

A. J. Schwarz and M. O. Leach, Implications of respiratory motion for the quantification of 2D MR spectroscopic imaging data in the abdomen, Physics in Medicine and Biology, vol.45, pp.2105-2116, 2000.

M. A. Selak, S. M. Armour, E. D. Mackenzie, H. Boulahbel, D. G. Watson et al., Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl hydroxylase, Cancer Cell, vol.7, pp.77-85, 2005.

A. Shukla-dave, R. K. Gupta, R. Roy, N. Husain, L. Paul et al., Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions, Magnetic Resonance Imaging, vol.19, pp.224-231, 2001.

D. Taieb, F. Sebag, A. Barlier, L. Tessonnier, F. F. Palazzo et al., 18 F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature, Journal of Nuclear Medicine, vol.50, pp.711-717, 2009.

D. Taieb, A. Varoquaux, C. C. Chen, and K. Pacak, Current and future trends in the anatomical and functional imaging of head and neck paragangliomas, Seminars in Nuclear Medicine, vol.43, pp.462-473, 2013.

D. Taieb, A. Kaliski, C. C. Boedeker, V. Martucci, T. Fojo et al., Current approaches and recent developments in the management of head and neck paragangliomas, Endocrine Reviews, vol.35, pp.795-819, 2014.

D. Taieb and H. J. Timmers, Shulkin BL & Pacak K 2014b Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma, Journal of Clinical Endocrinology and Metabolism, vol.99, pp.2337-2339

H. J. Timmers, C. C. Chen, J. A. Carrasquillo, M. Whatley, A. Ling et al., Staging and functional characterization of pheochromocytoma and paraganglioma by 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography, Journal of the National Cancer Institute, vol.104, pp.700-708, 2012.

A. Vicha, D. Taieb, and K. Pacak, Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma, Endocrine-Related Cancer, vol.21, pp.261-277, 2014.